Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-06-13 Sale | 2023-06-15 7:25 pm | BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 1,198,128 | $188.88 | $226,306,339 | 142,888,241 (Indirect) | View |
2023-06-08 Sale | 2023-06-12 9:57 pm | BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 2,956,689 | $201.98 | $597,183,858 | 144,086,369 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-03-26 5:26 pm | N/A N/A | BeiGene Ltd. | BGNE | Ball Titus B. Principal Accounting Officer | 0 | $0 | 38,155 (Direct) | View |
2024-03-11 Gift | 2024-03-13 5:04 pm | N/A N/A | BeiGene Ltd. | BGNE | Glazer Donald W. Director | 82,020 | $0 | 2,702,123 (Direct) | View |
2024-02-29 Option Award | 2024-03-04 5:24 pm | N/A 2034-02-28 | BeiGene Ltd. | BGNE | BRANDICOURT OLIVIER Director | 27,794 | $0 | 27,794 (Direct) | View |
2023-11-30 Gift | 2023-12-04 5:44 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 71,890 | $0 | 10,818,400 (Direct) | View |
2023-11-30 Other | 2023-12-04 5:44 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 172,372 | $0 | 10,818,400 (Indirect) | View |
2023-06-15 Option Award | 2023-06-20 7:08 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director | 39,897 | $0 | 64,389 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 7:01 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 39,897 | $0 | 56,589 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 7:00 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Malley Thomas Director | 39,897 | $0 | 103,671 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:59 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director | 39,897 | $0 | 64,389 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:58 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Glazer Donald W. Director | 39,897 | $0 | 2,811,118 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:56 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Dugan Margaret Director | 39,897 | $0 | 56,589 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:55 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel | 314,535 | $0 | 430,547 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:53 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 640,861 | $0 | 565,422 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:51 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer | 516,828 | $0 | 409,058 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:49 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 961,298 | $0 | 777,216 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:47 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 413,465 | $0 | 11,217,539 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 6:46 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,705,548 | $0 | 50,162,224 (Direct) | View |
Ownership | 2023-06-20 6:37 pm | N/A N/A | BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel | 0 | $0 | 304,941 (Direct) | View |
2023-06-15 Option Award | 2023-06-20 5:34 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner | 133,744 | $0 | 11,891,052 (Indirect) | View |
2023-06-15 Option Award | 2023-06-20 4:30 pm | N/A 2033-06-14 | BeiGene Ltd. | BGNE | Yi Qingqing Director | 39,897 | $0 | 56,589 (Direct) | View |
2023-03-16 Gift | 2023-03-20 5:37 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 67,444 | $0 | 10,804,074 (Direct) | View |
2023-03-08 Exercise | 2023-03-10 6:48 pm | N/A 2023-04-03 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 879,255 | $0 | 10,871,530 (Direct) | View |
2023-03-08 Exercise | 2023-03-10 6:48 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 67,635 | $0.13 | 10,871,530 (Direct) | View |